Mitobulin Solution for Injection

Mitobulin Solution for Injection
Eribulin Mesylate (0.5mg/ml)
Cheaper alternative availability
Already at the Best Price
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
About This Medicine
Product description & overview
Mitobulin Solution for Injection: Eribulin Mesylate (0.5 mg/ml)
Mitobulin solution for injection contains 0.5mg/ml of Eribulin mesylate. This potent chemotherapy agent is a highly effective treatment option for certain types of cancer.
Mechanism of Action: Mitobulin works by disrupting microtubule dynamics, inhibiting cell division and ultimately leading to the destruction of cancerous cells. Its mechanism of action makes it particularly effective against aggressive tumor growth.
Key Benefits:
* Proven effectiveness: Mitobulin is a clinically proven treatment for various types of cancers.
* Intravenous administration: The solution provides a convenient and effective method of administration through intravenous injection.
* Trusted Manufacturer: [Insert name of manufacturer] ensures the highest quality standards in manufacturing, guaranteeing purity and potency.
Contraindications: Consult with your healthcare professional before using Mitobulin Solution for Injection. Be aware of potential side effects and ensure it aligns with your specific treatment plan.
Note: This description is for informational purposes only. It should not be used as a substitute for professional medical advice or diagnosis. Always consult your physician regarding medications and treatments.
Active composition
Eribulin Mesylate
About Eribulin Mesylate
Eribulin Mesylate is an anti-cancer drug used to treat various malignancies, including breast cancer and liposarcoma. It works by inhibiting cancer cell division, effectively blocking tumor growth. Its significance in cancer therapy lies in its ability to manage advanced stages of these diseases. In summary, Eribulin Mesylate is essential for treating certain types of cancer.
How It Works
Eribulin Mesylate inhibits microtubule dynamics, preventing cancer cells from completing mitosis and thereby blocking tumor growth.
Dosage & How to Use
Dosage information not available. Please consult your doctor or pharmacist.
Safety Advice
Important precautions
Side Effect Occurrence
Based on clinical trials and patient reports.
Overall Tolerance
Most patients tolerate well
Common Side Effects
Safety Advice
Alcohol
It is not known whether it is safe to consume alcohol with Mitobulin Solution for Injection. Please consult your doctor.
High Risk
Pregnancy
Mitobulin Solution for Injection is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
Medical Advice
Driving
Mitobulin Solution for Injection may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Exercise Caution
Liver
Mitobulin Solution for Injection should be used with caution in patients with liver disease. Dose adjustment of Mitobulin Solution for Injection may be needed. Please consult your doctor.
Regular Checkup
Breastfeeding
Mitobulin Solution for Injection is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Consult Doctor
Kidney
Mitobulin Solution for Injection should be used with caution in patients with kidney disease. Dose adjustment of Mitobulin Solution for Injection may be needed. Please consult your doctor.
Regular Checkup
Customer Reviews
0 reviews for Mitobulin Solution for Injection
Products matching your search

Zyceva 150 Tablet

Zyceva 150 Tablet

Womazol Tablet

Womazol Tablet

Gratron Tablet

Gratron Tablet

Flutisol 250 DPI Capsule

Flutisol 250 DPI Capsule

Femoston Mini Tablet

Femoston Mini Tablet

Xtane Tablet

Xtane Tablet

Libset Tablet

Libset Tablet

Febuvel 80 Tablet
